HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Kansas City TCM Firm Persists With COVID-19 Claims Following US Regulators' Warning

Executive Summary

Latest warnings also include second and third businesses in US cannabidiol and hemp sector found making unlawful claims for treating and preventing COVID-19. Four of five firms warned apparently responded by removing violative claims from websites and social media posts.

You may also be interested in...

More US COVID-19 Warnings: India Homeopathy Clinic, California Colloidal Silver Seller

Dr. Dhole’s Sushanti gets US FDA warning for claiming homeopathy could keep COVID-19 "under control" while Honey Colony is latest colloidal silver supplement marketer warned about claiming the products could prevent the disease.

US Pandemic Fraud Reports To FTC Spark Warnings Against IV Drip Services, Sonar Treatment Provider

Complaints about potentially false COVID-19 claims are one source for FTC investigations to determine whether warnings or other enforcement are warranted. FTC's Consumer Sentinel Network includes nearly 10,000 pandemic fraud complaints, including reports of alleged losses from payments for goods and services not delivered or provided.

Bleach Mixtures Return To US Regulatory Radar Making COVID-19 Treatment Claims

FDA warning to "Genesis II Church of Health and Healing " wasn't its first to the organization about promoting a chlorine dioxide formulation, "Miracle Mineral Solution," as an unapproved new drug. 'Infowars' host Alex Jones also was warned about bogus COVID-19 claims.

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts